Evaluating visual fields is time consuming, subjective, and ambiguous.

Joanne Creighton, chief executive of Glaucoma UK, says that Higgy is an inspiration

Treating open and narrow angle glaucoma with CID

No serious adverse events, as determined by the investigators, were observed in either group

30,000 referrals for glaucoma in people aged 40–60 years in the last year; 30% of all referrals

OPTOMETRISTS have a key role in caring for glaucoma patients

A new class of implant to address the increasing need to treat glaucoma durably and with zero adverse effects.